Oragenics, Inc. (OGEN)
0.4109
+0.01
(+1.38%)
USD |
NYAM |
Oct 23, 16:00
0.4109
0.00 (0.00%)
After-Hours: 20:00
Oragenics Market Cap : 1.854M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 22, 2026 | 1.829M |
| October 21, 2026 | 1.863M |
| October 20, 2026 | 1.958M |
| October 19, 2026 | 1.904M |
| October 16, 2026 | 1.962M |
| October 15, 2026 | 1.967M |
| October 14, 2026 | 1.972M |
| October 13, 2026 | 2.016M |
| October 12, 2026 | 2.020M |
| October 09, 2026 | 2.058M |
| October 08, 2026 | 2.089M |
| October 07, 2026 | 2.256M |
| October 06, 2026 | 2.188M |
| October 05, 2026 | 2.193M |
| October 02, 2026 | 2.200M |
| October 01, 2026 | 2.166M |
| September 30, 2026 | 2.219M |
| September 29, 2026 | 2.166M |
| September 28, 2026 | 2.128M |
| September 25, 2026 | 2.201M |
| September 24, 2026 | 2.270M |
| September 23, 2026 | 2.193M |
| September 22, 2026 | 2.346M |
| September 21, 2026 | 2.342M |
| September 18, 2026 | 2.151M |
| Date | Value |
|---|---|
| September 17, 2026 | 2.342M |
| September 16, 2026 | 2.256M |
| September 15, 2026 | 2.200M |
| September 14, 2026 | 2.252M |
| September 11, 2026 | 2.157M |
| September 10, 2026 | 2.271M |
| September 09, 2026 | 2.324M |
| September 08, 2026 | 2.357M |
| September 04, 2026 | 2.301M |
| September 03, 2026 | 2.249M |
| September 02, 2026 | 2.284M |
| September 01, 2026 | 2.252M |
| August 31, 2026 | 2.300M |
| August 28, 2026 | 2.365M |
| August 27, 2026 | 2.400M |
| August 26, 2026 | 2.391M |
| August 25, 2026 | 2.347M |
| August 24, 2026 | 2.344M |
| August 21, 2026 | 2.369M |
| August 20, 2026 | 2.436M |
| August 19, 2026 | 2.392M |
| August 18, 2026 | 2.464M |
| August 17, 2026 | 2.414M |
| August 14, 2026 | 2.404M |
| August 13, 2026 | 2.392M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.394B |
| Alnylam Pharmaceuticals, Inc. | 29.96B |
| Anika Therapeutics, Inc. | 286.66M |
| Savara, Inc. | 864.73M |
| Vericel Corp. | 2.177B |
Market Cap Related Metrics
| Price to Book Value | 0.5051 |
| Price | 0.4109 |
| Earnings Yield | -871.9% |